SCHEMBL10030791

SCHEMBL10030791

CCOc1ccc(/C=C\c2cc(CO)c(CO)c(OC)c2)cc1N

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ TUBB1 Q9H4B7 8/20 0.51
▸ TUBB4A P04350 4/20 0.51
▸ TUBB P07437 4/20 0.51
▸ TUBA3C P0DPH7 4/20 0.51
▸ TUBA1B P68363 4/20 0.51
▸ TUBA4A P68366 4/20 0.51
▸ TUBB4B P68371 4/20 0.51
▸ TUBB3 Q13509 4/20 0.51
▸ TUBB2A Q13885 4/20 0.51
▸ TUBB8 Q3ZCM7 4/20 0.51
▸ TUBA3E Q6PEY2 4/20 0.51
▸ TUBA1A Q71U36 4/20 0.51
▸ TUBA1C Q9BQE3 4/20 0.51
▸ TUBB6 Q9BUF5 4/20 0.51
▸ TUBB2B Q9BVA1 4/20 0.51
▸ APP P05067 2/20 0.47
▸ ABL1 P00519 1/20 0.46
▸ ABCB1 P08183 1/20 0.46
▸ BCR P11274 1/20 0.46
▸ MAPT P10636 3/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12593827 0.91 TUBB1 (0.61) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL10030786 0.91 TUBB1 (0.61) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL13079742 0.87 TUBB1 (0.65) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL13223338 0.86 TUBB1 (0.47) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL17145723 0.86 TUBB1 (0.60) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL13456507 0.85 APP (0.57) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL12774239 0.84 TUBB1 (0.63) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL13223387 0.84 TUBB1 (0.49) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL10030792 0.82 TUBB1 (0.47) TUBB1TUBB4ATUBBTUBA3CTUBA1B
SCHEMBL10030779 0.81 KDM4E (0.59) APPMAPTNPC1RAB9AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20120046492-A1 Ethoxy Diphenyl Ethane Derivatives, Preparation Processes and Uses Thereof Zhejiang Wild Wind Pharmaceutical Co., Ltd. (CN) 2012-02-23 — — US disclosed
US-7838706-B2 Preparation and the use of ethoxy combretastatins and their prodrugs ZHEJIANG DADE PHARMACEUTICAL GROUP CO. LTD (CN) 2010-11-23 — — US disclosed
US-20090170956-A1 PREPARATION AND THE USE OF ETHOXY COMBRETASTATINS AND THEIR PRODRUGS ZHEJIANG DADE PHARMACEUTICAL GROUP CO. LTD (CN) 2009-07-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090170956-A1 PREPARATION AND THE USE OF ETHOXY COMBRETASTATINS AND THEIR PRODRUGS PHOSPHO1, TUBB3, TYMP TUBB1 5/4885TUBB4A 10/4885TUBB 4/4885
US-20120046492-A1 Ethoxy Diphenyl Ethane Derivatives, Preparation Processes and Uses Thereof TUBB1, TUBB, TUBB3 TUBB1 1/4885TUBB4A 6/4885TUBB 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback